| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.2 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |